Translation Through Collaboration
Built for Success
Northern Biologics was formed out of a unique academic drug discovery partnership, and collaboration is at the core of how we operate today. Supported by blue chip investors and partners, this approach enables us to quickly access new targets, innovative preclinical models, patient samples, and the deepest thinking on molecular mechanisms in immuno-oncology.
Northern Biologics has established collaborations with top academic centres including:
- University Health Network’s Princess Margaret Centre
- Memorial Sloan Kettering (MSK) Cancer Center
- Vall D’Hebron Institute of Oncology
- The Hospital for Sick Children
Northern Biologics is a privately held biotechnology company backed by Versant Ventures, a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies.
We have established an exclusive R&D collaboration with Celgene Corporation.